Abstract:Establishing and maintaining a healthy endothelium on vascular and intravascular devices is crucial for the prevention of thrombosis and stenosis. Generating a biofunctional surface on vascular devices to recruit endothelial progenitor cells (EPCs) and endothelial cells (ECs) has proven efficient in promoting in situ endothelialization. However, molecules conventionally used for EPC/EC capturing generally lack structural stability, capturing specificity, and biological functionalities, which have limited their applications. Discovery of effective, specific, and structurally stable EPC/EC capturing ligands is desperately needed. Using the high-throughput One-Bead One-Compound combinatorial library screening technology, we recently identified a disulfide cyclic octa-peptide LXW7 (cGRGDdvc), which possesses strong binding affinity and functionality to EPCs/ECs, weak binding to platelets, and no binding to inflammatory cells. Because LXW7 is cyclic and 4 out of the 8 amino acids are unnatural D-amino acids, LXW7 is highly proteolytically stable. In this study, we applied LXW7 to modify small diameter vascular grafts using a Click chemistry approach. In vitro studies demonstrated that LXW7-modified grafts significantly improved EPC attachment, proliferation and endothelial differentiation and suppressed platelet attachment. In a rat carotid artery bypass model, LXW7 modification of the small diameter vascular grafts significantly promoted EPC/EC recruitment and rapidly achieved endothelialization. At 6 weeks after implantation, LXW7-modified grafts retained a high patency of 83%, while the untreated grafts had a low patency of 17%. Our results demonstrate that LXW7 is a potent EPC/EC capturing and platelet suppressing ligand and LXW7-modified vascular grafts rapidly generate a healthy and stable endothelial interface between the graft surface and the circulation to reduce thrombosis and improve patency. STATEMENT OF SIGNIFICANCE: In this study, One-Bead One-Compound (OBOC) technology has been applied for the first time in discovering bioactive ligands for tissue regeneration applications. Current molecules used to modify artificial vascular grafts generally lack EPC/EC capturing specificity, biological functionalities and structural stability. Using OBOC technology, we identified LXW7, a constitutionally stable disulfide cyclic octa-peptide with strong binding affinity and biological functionality to EPCs/ECs, very weak binding to platelets and no binding to inflammatory cells. These characteristics are crucial for promoting rapid endothelialization to prevent thrombosis and improve patency of vascular grafts. LXW7 coating technology could be applied to a wide range of vascular and intravascular devices, including grafts, stents, cardiac valves, and catheters, where a "living" endothelium and healthy blood interface are needed.

Fabrication of Endothelial Progenitor Cell Capture Surface Via DNA Aptamer Modifying Dopamine/polyethyleneimine Copolymer Film

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Immobilization of serum albumin and peptide aptamer for EPC on polydopamine coated titanium surface for enhanced in-situ self-endothelialization.

Co-immobilization of CD133 Antibodies, Vascular Endothelial Growth Factors, and REDV Peptide Promotes Capture, Proliferation, and Differentiation of Endothelial Progenitor Cells.

Functionalization of the Surface of Electrospun Poly(Epsilon-Caprolactone) Mats Using Zwitterionic Poly(Carboxybetaine Methacrylate) and Cell-Specific Peptide for Endothelial Progenitor Cells Capture

Re-endothelialization of Decellularized Scaffolds with Endothelial Progenitor Cell Capturing Aptamer: A New Strategy for Tissue-Engineered Heart Valve

Surface tailoring for selective endothelialization and platelet inhibition via a combination of SI-ATRP and click chemistry using Cys-Ala-Gly-peptide.

Discovery and Characterization of A Potent and Specific Peptide Ligand Targeting Endothelial Progenitor Cells and Endothelial Cells for Tissue Regeneration

Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization.

Substrate-mediated Delivery of Gene Complex Nanoparticles Via Polydopamine Coating for Enhancing Competitiveness of Endothelial Cells.

Combinatorial coating of adhesive polypeptide and anti-CD34 antibody for improved endothelial cell adhesion and proliferation

Antimicrobial Surfaces Grafted Random Copolymers With Redv Peptide Beneficial For Endothelialization

Antimicrobial Surfaces Grafted Random Copolymers with REDV Peptide Beneficial for Endothelialization.

Site-directed Immobilization of Antibodies Onto Blood Contacting Grafts for Enhanced Endothelial Cell Adhesion and Proliferation

Rapid Endothelialization of Small Diameter Vascular Grafts by a Bioactive Integrin-Binding Ligand Specifically Targeting Endothelial Progenitor Cells and Endothelial Cells.

Preparation of Vascular Endothelial Cadherin Loaded-Amphoteric Copolymer Decorated Coronary Stents for Anticoagulation and Endothelialization

Direct Adsorption of Anti-CD34 Antibodies on the Nano-Porous Stent Surface to Enhance Endothelialization.

Dual functionalization of poly(ε-caprolactone) film surface through supramolecular assembly with the aim of promoting in situ endothelial progenitor cell attachment on vascular grafts.

A Novel Scaffold for Endothelial Progenitor Cells in Tissue Engineered Vascular Grafts

Novel Human Endothelial Cell-Engineered Polyurethane Biomaterials for Cardiovascular Biomedical Applications.

Toward Endothelialization Via Vascular Endothelial Growth Factor Immobilization on Cell-Repelling Functional Polyurethanes.